Published in Arch Biochem Biophys on September 15, 1996
Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature (1992) 8.39
Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys (1985) 4.59
International code for phytolith nomenclature 1.0. Ann Bot (2005) 2.87
Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem (1993) 2.79
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Stoichiometry of vectorial H+ movements coupled to electron transport and to ATP synthesis in mitochondria. Proc Natl Acad Sci U S A (1978) 1.85
Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R (1990) 1.79
Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J Biol Chem (1994) 1.67
Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol (1974) 1.59
Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord (2009) 1.58
Probing the partly folded states of proteins by limited proteolysis. Fold Des (1997) 1.52
Probing the conformational state of apomyoglobin by limited proteolysis. J Mol Biol (1997) 1.40
Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol (1976) 1.40
Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol (1974) 1.39
Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. Am J Pathol (1974) 1.27
The structural basis for the regulation of tissue transglutaminase by calcium ions. Eur J Biochem (1999) 1.27
Differential ethylene-inducible expression of cellulase in pepper plants. Plant Mol Biol (1995) 1.24
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med (1980) 1.23
Proton translocation stoichiometry of cytochrome oxidase: use of a fast-responding oxygen electrode. Proc Natl Acad Sci U S A (1982) 1.21
Influence of epinephrine on the aggregation response of aspirin-treated platelets. Prostaglandins Med (1980) 1.18
Inhibitory action of quercetin on xanthine oxidase and xanthine dehydrogenase activity. Pharmacol Res Commun (1985) 1.16
Lipid peroxidation induced by cercosporin as a possible determinant of its toxicity. Chem Biol Interact (1979) 1.13
Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol (1975) 1.12
The interaction between cold and light controls the expression of the cold-regulated barley gene cor14b and the accumulation of the corresponding protein. Plant Physiol (1999) 1.10
Measurement of ionized calcium in blood platelets with a new generation calcium indicator. Biochem Biophys Res Commun (1985) 1.07
An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. Am J Pathol (1978) 1.07
Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials (2000) 1.06
Labile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal platelets. Br J Haematol (1975) 1.05
Two classes of agonist-sensitive Ca2+ stores in platelets, as identified by their differential sensitivity to 2,5-di-(tert-butyl)-1,4-benzohydroquinone and thapsigargin. Biochem J (1995) 1.04
Cognitive outcome and early indices of severity of head injury. J Neurosurg (1983) 1.03
Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. Am J Pathol (1978) 1.03
Influence of the ionophore A23187 on the plastic behavior of normal erythrocytes. Am J Pathol (1977) 1.03
Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Chem (1996) 1.01
Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res (1986) 0.99
Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol (1998) 0.99
Surface-activated bovine platelets do not spread, they unfold. Am J Pathol (1990) 0.99
Effects of a microtubule stabilizing agent on the response of platelets to vincristine. Blood (1982) 0.97
Acetoacetate activation and oxidation in kidney and heart mitochondria. Biochim Biophys Acta (1969) 0.97
Stoichiometry of H+ translocation coupled to electron flow from succinate to cytochrome c in mitochondria. J Biol Chem (1979) 0.97
Recycling of platelet phosphorylation and cytoskeletal assembly. J Cell Biol (1984) 0.96
Ca2+ influx in platelets: activation by thrombin and by the depletion of the stores. Effect of cyclic nucleotides. Biochem J (1994) 0.95
Influence of a microtubule stabilizing agent on platelet structural physiology. Am J Pathol (1983) 0.93
Bypasses of the antimycin a block of mitochondrial electron transport in relation to ubisemiquinone function. Biochim Biophys Acta (1984) 0.93
Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun (1983) 0.92
The pH-sensitive dye acridine orange as a tool to monitor exocytosis/endocytosis in synaptosomes. J Neurochem (1999) 0.92
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis (1983) 0.91
Oxidation of long chain fatty acids by rat liver mitochondria. J Biol Chem (1967) 0.90
Arachidonate-induced platelet aggregation in the dog. Thromb Res (1979) 0.90
Decerebrate rigidity in acute head injury. J Neurosurg (1977) 0.90
Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets. Am J Hematol (1981) 0.90
An improved method for the extraction of endogenous platelet serotonin. J Lab Clin Med (1976) 0.89
Modification of the xanthine-converting enzyme of perfused rat heart during ischemia and oxidative stress. Free Radic Biol Med (1988) 0.89
Antisterility and antivitamin K activity of d-alpha-tocopheryl hydroquinone in the vitamin E-deficient female rat. J Nutr (1975) 0.89
Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. Biochim Biophys Acta (1982) 0.88
Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost (1986) 0.88
Ca2+ efflux from platelets. Control by protein kinase C and the filling state of the intracellular Ca2+ stores. Eur J Biochem (1994) 0.88
The influence of glutathione depleting agents on human platelet function. Thromb Res (1989) 0.87
Involvement of nuclear factor-kappa B (NF-kappaB) activation in mitogen-induced lymphocyte proliferation: inhibitory effects of lymphoproliferation by salicylates acting as NF-kappaB inhibitors. Biochem Pharmacol (2001) 0.86
The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am J Pathol (1977) 0.86
Unbalanced plasma control of TxA2 and PGI2 synthesis in vitamin E-deficient rats. Am J Physiol (1983) 0.86
Suprascapular nerve entrapment. Acta Neurochir Suppl (2005) 0.86
On the location of the H+-extruding steps in site 2 of the mitochondrial electron transport chain. J Biol Chem (1980) 0.86
Mitochondrial lipid peroxidation by cumene hydroperoxide and its prevention by succinate. Biochim Biophys Acta (1982) 0.85
Molecular characterization of the functionally distinct hemoglobins of the Antarctic fish Trematomus newnesi. J Biol Chem (1994) 0.85
Limited proteolysis of cytochrome c in trifluoroethanol. FEBS Lett (1995) 0.85
Salicylate fails to prevent the inhibitory effect of 5,8,11,14-eicosatetraynoic acid on human platelet cyclo-oxygenase and lipoxygenase activities. Biochim Biophys Acta (1983) 0.85
Opsoclonus and palatal myoclonus during prolonged post-traumatic coma. A clinico-pathologic study. Eur Neurol (1977) 0.85
Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. Biochem Biophys Res Commun (1988) 0.84
Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol (1978) 0.84
Modification of human platelet response to sodium arachidonate by membrane modulation. Prostaglandins Med (1981) 0.83
Cytochrome b6/f complex from the cyanobacterium Synechocystis 6803: evidence of dimeric organization and identification of chlorophyll-binding subunit. FEBS Lett (1997) 0.83
Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function. Biochim Biophys Acta (1980) 0.83
Influence of the calcium-sensitive fluorophore, Quin 2, on platelet function. Blood (1986) 0.82
Glutathione levels in human platelets display a circadian rhythm in vitro. Thromb Res (1985) 0.82
Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog. Blood (1980) 0.82
Ganglioside GM1 protection from apoptosis of rat heart fibroblasts. Arch Biochem Biophys (1999) 0.82
Platelet activation by diacylglycerol or ionomycin is inhibited by nitroprusside. Biochim Biophys Acta (1991) 0.82
5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J Microencapsul (2001) 0.82
Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif Organs (1999) 0.82
Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function. Prostaglandins Med (1980) 0.82
Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with hermansky-Pudlak syndrome. Prostaglandins Med (1981) 0.81
Enhanced protein thermostability by Ala-->Aib replacement. Biochemistry (1998) 0.81
Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog. Can J Physiol Pharmacol (1982) 0.81
Respiration-coupled H+ ejection by mitochondria. Ann N Y Acad Sci (1980) 0.81
Changes in pericardial calcification due to antiplatelet agents: in vitro studies. Artif Organs (1998) 0.81
The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes. Prostaglandins Med (1980) 0.80
Pathways of hydrogen peroxide generation in guinea pig cerebral cortex mitochondria. Biochem Biophys Res Commun (1988) 0.80
Thermosensitization by increasing intracellular acidity with amiloride and its analogs. Int J Radiat Oncol Biol Phys (1994) 0.80
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. Scand J Haematol (1984) 0.80
Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets. Biochem J (1988) 0.80
Inhibition of lipid peroxidation by alpha-tocopherolquinone and alpha-tocopherolhydroquinone. Biochem Int (1985) 0.80
Fructose-1,6-diphosphate inhibits platelet activation. Biochem Pharmacol (1992) 0.80
Chemical synthesis and structural characterization of the RGD-protein decorsin: a potent inhibitor of platelet aggregation. Protein Sci (1998) 0.79
Generation of hydrogen peroxide by cerebral-cortex synaptosomes. Stimulation by ionomycin and plasma-membrane depolarization. Eur J Biochem (1989) 0.79
Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate. Biochim Biophys Acta (1989) 0.79
Effect of Amrinone, a cardiotonic drug, on hemodynamics and platelet function. Prostaglandins Med (1981) 0.79
Smoking and platelet labile aggregation stimulating substance (LASS) synthesizing activity. Thromb Res (1976) 0.79